Somatostatin Receptor Imaging with 68Ga DOTATATE PET/CT: Clinical Utility, Normal Patterns, Pearls, and Pitfalls in Interpretation

MS Hofman, WFE Lau, RJ Hicks - Radiographics, 2015 - pubs.rsna.org
Gallium 68 (68Ga) 1, 4, 7, 10-tetraazacyclododecane-1, 4, 7, 10-tetraacetic acid (DOTA)–
octreotate (DOTATATE, GaTate) positron emission tomography (PET)/computed tomography …

High management impact of Ga‐68 DOTATATE (GaTate) PET/CT for imaging neuroendocrine and other somatostatin expressing tumours

MS Hofman, G Kong, OC Neels, P Eu… - Journal of medical …, 2012 - Wiley Online Library
Abstract Introduction: Ga‐68 DOTATATE (Ga‐octreotate, GaTate) positron emission
tomography (PET)/CT has multiple advantages compared with conventional and In‐111 …

Current concepts in 68Ga-DOTATATE imaging of neuroendocrine neoplasms: interpretation, biodistribution, dosimetry, and molecular strategies

L Bodei, V Ambrosini, K Herrmann… - Journal of Nuclear …, 2017 - Soc Nuclear Med
68Ga-DOTATATE PET/CT provides information on the location of somatostatin receptor–
expressing tumors. Integrating this imaging data effectively in patient care requires the …

Comparison of 68Ga-DOTANOC and 68Ga-DOTATATE PET/CT within patients with gastroenteropancreatic neuroendocrine tumors

D Wild, JB Bomanji, P Benkert, H Maecke… - Journal of Nuclear …, 2013 - Soc Nuclear Med
Somatostatin receptor PET tracers such as [68Ga-DOTA, 1-Nal3]-octreotide (68Ga-
DOTANOC) and [68Ga-DOTA, Tyr3]-octreotate (68Ga-DOTATATE) have shown promising …

Gallium-68 PET: a new frontier in receptor cancer imaging

A Al-Nahhas, Z Win, T Szyszko, A Singh… - Anticancer …, 2007 - ar.iiarjournals.org
Neuroendocrine tumours (NET) are rare tumours that occur most commonly in the GI tract.
Various labelled somatostatin analogues are used to image NET expressing somatostatin …

68Ga-DOTATOC versus 68Ga-DOTATATE PET/CT in functional imaging of neuroendocrine tumors

TD Poeppel, I Binse, S Petersenn… - Journal of nuclear …, 2011 - Soc Nuclear Med
Radiolabeled somatostatin analogs represent valuable tools for both in vivo diagnosis and
therapy of neuroendocrine tumors (NETs) because of the frequent tumoral overexpression of …

Diagnostic role of Gallium-68 DOTATOC and Gallium-68 DOTATATE PET in patients with neuroendocrine tumors: a meta-analysis

J Yang, Y Kan, BH Ge, L Yuan, C Li… - Acta radiologica, 2014 - journals.sagepub.com
Background Gallium-68 somatostatin receptor positron emission tomography (PET) has
been used in the diagnosis of neuroendocrine tumors (NETs). The compounds often used in …

Comparison of 68Ga-DOTATATE and 68Ga-DOTANOC PET/CT imaging in the same patient group with neuroendocrine tumours

L Kabasakal, E Demirci, M Ocak, C Decristoforo… - European journal of …, 2012 - Springer
Purpose Recent studies have suggested that positron emission tomography (PET) imaging
with 68 Ga-labelled DOTA-somatostatin analogues (SST) like octreotide and octreotate is …

Impact of 68Ga-DOTATATE PET/CT on the management of neuroendocrine tumors: the referring physician's perspective

K Herrmann, J Czernin, EM Wolin… - Journal of Nuclear …, 2015 - Soc Nuclear Med
Somatostatin receptor imaging with 68Ga-DOTATATE PET/CT (DOTATATE) is increasingly
used for managing patients with neuroendocrine tumors. The objective of this study was to …

The Utility of 68Ga-DOTATATE Positron-Emission Tomography/Computed Tomography in the Diagnosis, Management, Follow-Up and Prognosis of Neuroendocrine …

A Tirosh, E Kebebew - Future Oncology, 2017 - Taylor & Francis
Neuroendocrine tumors (NETs) are rare neoplasms that emerge mainly from the GI tract,
pancreas and respiratory tract. The incidence of NETs has increased more than sixfold in the …